HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bush Establishes Import Safety Group As Congress Grills FDA On Food Safety

This article was originally published in The Tan Sheet

Executive Summary

President Bush established a working group July 18 to help guarantee the safety of food and other products shipped into the U.S

You may also be interested in...



Safety Woes Make Country Of Origin Labeling “Foregone Conclusion” – Execs

Supplement firms should not underestimate the potential for consumers' concerns about the safety of raw materials imported from China to affect their sales, industry executives said Oct. 6 at the Council for Responsible Nutrition's annual conference

FDA Reconsiders ORA Reorganization As Questions From Congress Continue

FDA's Aug. 1 decision to temporarily suspend plans to close seven of its 13 field laboratories as part of its Office of Regulatory Affairs reorganization follows repeated protests and inquiries from Capitol Hill, including a July 31 letter from two of the proposal's chief critics

Stirring Up Food Safety Discussions On HHS Officials’ Agenda In Beijing

Department of Health and Human Services senior officials are consulting with Chinese food and drug regulators in China to "pave the way" for discussions on developing U.S.-China agreements for increased safety of food and feed and on drugs and medical devices, according to HHS Secretary Michael Leavitt

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS137842

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel